344 related articles for article (PubMed ID: 26502410)
1. Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.
Aggarwal N; Santiago AM; Kessel D; Sloane BF
Breast Cancer Res Treat; 2015 Nov; 154(2):251-62. PubMed ID: 26502410
[TBL] [Abstract][Full Text] [Related]
2. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
Tsai SR; Yin R; Huang YY; Sheu BC; Lee SC; Hamblin MR
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):123-30. PubMed ID: 25462575
[TBL] [Abstract][Full Text] [Related]
3. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
4. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
5. Expression of proapoptotic BAX and TP53 genes and antiapoptotic BCL-2 gene in MCF-7 and T-47D tumour cell cultures of the mammary gland after a photodynamic therapy with photolon.
Płonka J; Latocha M; Kuśmierz D; Zielińska A
Adv Clin Exp Med; 2015; 24(1):37-46. PubMed ID: 25923085
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
8. Concomitant treatment with temozolomide enhances apoptotic cell death in glioma cells induced by photodynamic therapy with talaporfin sodium.
Miki Y; Akimoto J; Omata H; Moritake K; Hiranuma M; Hironaka C; Fujiwara Y; Beppu M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):556-64. PubMed ID: 25262961
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.
Tong ZS; Miao PT; Liu TT; Jia YS; Liu XD
Acta Pharmacol Sin; 2012 Oct; 33(10):1319-24. PubMed ID: 22842729
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells.
Miki Y; Akimoto J; Yokoyama S; Homma T; Tsutsumi M; Haraoka J; Hirano K; Beppu M
Biol Pharm Bull; 2013; 36(2):215-21. PubMed ID: 23196427
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of photodynamic therapy with hematoporphyrin monomethyl ether on VX2 tumors implanted in the rectal submucosa of rabbits.
Gao H; Shi L; Yin H; Wang H; Shen J; Wang C; Niu Q; Li Y; Li W; Dong M; Lu Y
J Photochem Photobiol B; 2016 Oct; 163():162-9. PubMed ID: 27576112
[TBL] [Abstract][Full Text] [Related]
12. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
Popovic A; Wiggins T; Davids LM
J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
[TBL] [Abstract][Full Text] [Related]
13. Vascular effects of photodynamic and pulsed dye laser therapy protocols.
Channual J; Choi B; Osann K; Pattanachinda D; Lotfi J; Kelly KM
Lasers Surg Med; 2008 Nov; 40(9):644-50. PubMed ID: 18951421
[TBL] [Abstract][Full Text] [Related]
14. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
Harvey EH; Webber J; Kessel D; Fromm D
Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model.
Middelkamp-Hup MA; Sánchez-Carpintero I; Kossodo S; Waterman P; González S; Mihm MC; Anderson RR
J Invest Dermatol; 2003 Sep; 121(3):634-9. PubMed ID: 12925226
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of photodynamic therapy via a sequential targeting protocol.
Kessel D; Reiners JJ
Photochem Photobiol; 2014; 90(4):889-95. PubMed ID: 24617972
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic Therapy Mediated by a Novel Chlorin Derivative, TONS 501-Na, in EMT6 cells.
Osaki T; Sakata I; Uto Y; Azuma K; Murahata Y; Tsuka T; Itoh N; Imagawa T; Okamoto Y
Anticancer Res; 2017 Apr; 37(4):1723-1728. PubMed ID: 28373434
[TBL] [Abstract][Full Text] [Related]
19. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
Kasuya K; Shimazu M; Suzuki M; Kuroiwa Y; Usuda J; Itoi T; Tsuchida A; Aoki T
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors.
Schmidt MH; Reichert KW; Ozker K; Meyer GA; Donohoe DL; Bajic DM; Whelan NT; Whelan HT
Pediatr Neurosurg; 1999 May; 30(5):225-31. PubMed ID: 10461068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]